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Hump-nosed viper bites are common in the Indian subcontinent. In the past, hump-nosed vipers (Hypnale species)
were considered moderately venomous snakes whose bites result mainly in local envenoming. However, a variety
of severe local effects, hemostatic dysfunction, microangiopathic hemolysis, kidney injury and death have been
reported following envenoming by Hypnale species. We systematically reviewed the medical literature on the
epidemiology, toxin profile, diagnosis, and clinical, laboratory and postmortem features of hump-nosed viper
envenoming, and highlight the need for development of an effective antivenom.
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Hump-nosed viper (Hypnale) bite is an important yet
under-recognized cause of morbidity and mortality in
Southern India and Sri Lanka, where three species have
been identified, namely Hypnale hypnale, H. zara and H.
nepa. Specifically, H. hypnale has been reported from Sri
Lanka and the Western Ghats of South India, while the
other two species are endemic to Sri Lanka alone [1]. In
Sri Lanka, this small pit viper is known as ‘polon-the-
lissa’ (viper with an upturned lip) or ‘kunakatuwa’ (refer-
ring to the necrotic effects at the bite site) in Sinhala,
and ‘kopi viriyan’ (coffee snake) in Tamil. In Kerala,
India, it is called ‘churrutta’ in the Malayalam language.
Although formerly thought to result only in minor or
local envenoming, hump-nosed viper (HNV) bite is now
known to cause serious systemic toxicity and fatalities
[2-6]. Clinical manifestations of systemic envenoming by
this snake include acute kidney injury, hematological
manifestations, and other organ involvement, in some
cases leading to death. Several unusual manifestations
have also been reported. HNV is now recognized as a
highly venomous snake, alongside the Indian cobra (Naja
naja), the common krait (Bungarus caeruleus), Russell's
viper (Daboia russelii) and the saw-scaled viper (Echis
carinatus) [3]. It is the commonest cause of snakebite* Correspondence: mcs627@gmail.com
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article, unless otherwise stated.envenoming in Sri Lanka [7,8]. The clinical and epidemio-
logical importance of HNV bite is under-recognized,
and currently no effective antivenom exists. In this paper
we review the published literature on the epidemiology,
clinical manifestations, and treatment of envenoming
following HNV bite.
We performed a systematic review of the published lit-
erature. The databases Medline, Embase and Scopus were
searched using the terms ‘hypnale’ OR ‘hump nosed’ OR
‘hump-nosed viper’ in any field, with no date limits. The
search was performed on March 22, 2014. A combined
search of Medline and Embase resulted in 50 hits; Scopus
produced 62 hits. Databases were merged and duplicates
removed. The abstracts were read through by two authors
independently (MCS and SR), and relevant papers identi-
fied. Related references were also included. Data was ex-
tracted by two authors (MCS and SR), and crosschecked
by the other two authors (MRN and MJY). Where con-
flicting data were present, a consensus was arrived upon
by discussion between all the authors. The inter-rater
agreement was 100%. The full text was obtained in 45 pa-
pers. A total of 40 papers provided useful data.Review
Epidemiology
HNV accounts for between 27 and 77% of venomous
snakebites in Sri Lanka and south India [4,5,8,9]. In
southwestern India (Kerala), in the year 2007, H. hypnale
was identified as a common and dangerous source oftral Ltd. This is an Open Access article distributed under the terms of the
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been subsequently recorded in India following HNV
envenoming [5,10]. In a prospective multicenter study
involving ten hospitals in Sri Lanka, 302 HNV bite vic-
tims were identified out of 860 patients with bites by
identified snakes (35%). These were mostly men between
the ages 11 and 51 years, bitten commonly at night on
their feet or ankles near their homes [4]. The case fatal-
ity rate resulting from HNV bite was 1.7%, all due to
acute kidney injury. Similar findings had been reported
previously in a single-center prospective study in Avissa-
wella, Sri Lanka, although fatalities were not seen [11].
HNV was the commonest amongst cases of identified
snakebite, in a three-year hospital based observational
study from 2006 in the central hills of Sri Lanka [12]. Not-
ably, the majority (61%) of victims had been bitten in a
home garden. However, in this study there were large
numbers of unidentified snakebites that did not result in
envenoming. Another recent prospective hospital-based
clinical study in Sri Lanka of proven HNV bites identified
114 definite cases [2]. Most bites were on the lower limbs
and during the daytime. H. hypnale bites were usually in
home gardens, whilst H. zara and H. nepa bites occurred
in the forests and tea estates respectively. In a large case
series spanning 1990–2008, of 1543 patients with HNV
bite, 4.34% were found to have developed systemic enve-
noming; only two patients died [13]. The pattern of bites
among children may differ slightly from that of the adult
population. One study in the pediatric population showed
that bites in children occur most commonly on the feet,
and then the hands, mostly following provocation, and
take place between 5 and 10 pm [14]. Overall, systemic
envenoming is seen in a significant proportion of patients
with HNV bite, although mortality appears to be low.
Most reported cases of systemic envenoming are with H.
hypnale [2]. A single case report describes coagulopathy
and acute kidney injury leading to death after confirmed
H. zara envenoming [15]. There are no reported cases of
systemic envenoming or fatality due to a H. nepa bite.
Toxin profile
In vitro studies have found that the three Hypnale venoms
in Sri Lanka display similar chromatographic profiles [16].
Potent cytotoxicity, weak neurotoxic and myotoxic activ-
ity, mild procoagulant activity and also phospholipase ac-
tivity are present in HNV venom. These activities are not
neutralized by the locally available polyvalent antivenom.
High activity levels of thrombin-like enzyme, proteases,
phospholipase A2, L-amino acid oxidase and hyaluroni-
dase may explain the hematological manifestations de-
scribed below. The thrombin-like enzyme, which is highly
acidic, is likely to exist in multiple isoforms (as evidenced
by its chromatographic patterns). The hemorrhagic and
necrotic activities of the venom are probably associatedwith the proteolytic enzyme found mainly in the basic
fraction [17]. In vivo studies in mice also suggest that H.
hypnale venom is more toxic compared to the other two
species, with histopathological changes as well as lethality
occurring with lower doses of venom [18].
Diagnosis
Identification of the snake by medical personnel (or
sometimes a herpetologist) viewing the dead snake or a
photograph is the commonest means of diagnosing Hyp-
nale snakebite [2,9,13]. However, misidentification rates
as high as 6% by hospital staff have been reported [19].
Misidentification commonly occurs between Russell’s
viper and the saw-scaled viper, which may contribute to
confusion regarding clinical manifestations of severity
[5,19]. Where the snake is unidentified, syndromic diag-
nosis is a very useful tool; this is frequently used in clin-
ical settings [19]. The basis of syndromic diagnosis is
that, where the snake has not been identified visually, it
is possible to make an identification based on the clinical
syndrome it produces, using a validated algorithm. Its
specificity for Russell’s viper and HNV is high, albeit
with poor sensitivity. The key clinical features in this
tool favoring HNV bite are local envenoming, incoagul-
able blood, and renal failure; however, these are also pro-
voked by Russell’s viper [19].
Alternate scoring systems have been suggested but are
insensitive in diagnosing HNV and saw scaled viper
envenoming, although they help differentiate HNV bite
from Russell's viper, krait and cobra bites [20]. Immune
assays based on the antigenic profile of viper toxins that
may differentiate between species of vipers have been
tested. These have the potential to become valuable tools
in diagnosing and differentiating HNV bite from other
snakebites [21]. Cross-reactivity studies using indirect
ELISA have shown that anti-Hypnale hypnale IgG cross-
reacts extensively with several Asiatic crotalid venoms.
Further studies have shown that this assay is able to dis-
tinguish and quantify venoms of H. hypnale, Daboia rus-
selii and Echis carinatus sinhaleyus.
Envenoming
Local effects
Pain and fang marks are invariably found after HNV
bite. Local envenoming is the commonest manifestation,
with an incidence of approximately 90% [2,4]. This can
be severe, and lead to tissue necrosis. Local pain, swell-
ing, induration, local hemorrhagic blister formation,
local bleeding, local necrosis, need for amputation and
skin grafting, and regional lymphadenopathy have all
been reported [2,4,11,22]. However, severe local enve-
noming with proximal spread is relatively less common,
and was seen in only 16 of 114 study subjects in a recent
hospital-based study [2].
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Although HNV bite was previously thought only to re-
sult in local envenoming, systemic effects are now a rec-
ognized phenomenon, with more than one organ system
being affected [2,4,11,13]. The variable frequency and se-
verity of systemic envenoming could at least partly be
explained by variations in toxicity between the different
Hypnale species [2]. HNV bites appear to result in a
higher incidence of both local and systemic effects in
children, especially those under three years; systemic ef-
fects appear to occur early on, and show an inverse rela-
tionship to body surface area [14].
Vascular and hematological manifestations
Individual reports of coagulopathy following hump-
nosed viper envenoming were reported in the 1990s
[23-25]. In a prospective study of 56 patients with
proven HNV bites, 12 patients (21.4%) developed con-
tinued oozing of blood from the site of the bite, with
prolonged clotting time [24]. Low fibrinogen levels and
increased fibrinogen degradation products in plasma
were also demonstrated in these patients. Bleeding time,
platelet count, prothrombin time, and partial thrombo-
plastin time with kaolin were normal. The authors sug-
gested the use of whole-blood clotting time to monitor
cases of hump-nosed viper bite; this is standard practice
in hospitals in Sri Lanka now. In a recent paper on syn-
dromic diagnosis of snakebite, the authors suggested
that coagulopathy was present in 39% of 302 patients
with HNV bite, making it the second commonest mani-
festation after local envenoming [19]. Even where the
whole-blood clotting time is normal, mild coagulopathy,
evidenced by slight elevation of INR, low fibrinogen and
factors V and VIII have been associated with HNV bite
[26]. It is postulated that these abnormalities occur due
to a thrombin-like enzyme contained in the venom; the
clinical significance of these abnormalities is unclear.
Microangiopathic hemolytic anemia with thrombocy-
topenia, coagulopathy, fibrinolysis, thrombocytopenia or
spontaneous systemic hemorrhage, and a case of hemolytic
uremic syndrome, have been reported with HNV bite
[5,6,26-28]. Consumptive coagulopathy has been pur-
ported to be the mechanism for these manifestations in
some cases [27,28]. Isbister [29] described this venom-
induced coagulopathy as constituting the commonest
coagulopathy associated with snake envenoming. This
has been likened to disseminated intravascular coagula-
tion (DIC), because of certain similarities seen between
the two conditions, e.g., elevated D-dimer, prolonged
prothrombin time, and low fibrinogen; however, import-
ant differences between venom-induced coagulopathy
and DIC have been demonstrated [29]. The onset and
resolution were rapid, while there was no evidence of ei-
ther systemic microthrombi or end-organ failure. In aportion of patients with venom-induced coagulopathy,
however, a clinical syndrome consistent with thrombotic
microangiopathy has been reported, characterized by
thrombocytopenia, microangiopathic hemolytic anemia
and acute kidney injury. This venom induced coagulopa-
thy-related thrombotic microangiopathy appears to occur
with several different snakebites worldwide, including vi-
pers and elapids.
Renal toxicity
In mouse model studies, histopathogical examination of
the kidneys have revealed proximal tubular cell injury
and acute tubular necrosis with intact basement mem-
brane, indicating possible direct nephrotoxicity following
HNV envenoming [18]. Renal toxicity was observed in
around 19% of cases with HNV bite in a recent study,
while death following acute kidney injury is well docu-
mented [4,6,30,31]. Renal toxicity is characterized by fea-
tures of acute kidney injury, i.e., oliguria, dark urine,
fluid retention, uremia and elevated serum creatinine,
often requiring dialysis [4-6,14,15,23,27,28,30,32]. Both
enzymatic activity in venom and immunologic mecha-
nisms have been implicated in causing renal damage fol-
lowing snakebite, with the latter playing only a minor
role. Hemodynamic alterations caused by vasoactive me-
diators and cytokines also contribute to renal damage
[33]. Bilateral cortical necrosis, characterized by irregular
areas of coagulative necrosis involving both glomeruli
and tubules in the cortices, have been demonstrated in
postmortem studies as far back as in 1970 [30]. Similar
postmortem findings have been described in a case of
H. zara envenoming complicated by coagulopathy [15].
In a prospective observational study carried out at the
Nephrology Unit, Kandy, Sri Lanka from October 2010
to October 2011, out of 11 patients with acute kidney in-
jury following HNV bites, all required renal replacement
therapy, seven developed thrombotic microangiopathy
with evidence of microangiopathic hemolytic anemia
(MAHA), thrombocytopenia and severe anemia necessi-
tating multiple blood transfusions, and two progressed
to chronic renal failure [6]. Autopsy in two fatalities
demonstrated thrombotic microangiopathy. The authors
queried a causal link between thrombosis and renal
damage. Chronic kidney disease, whose occurrence is
predicted by the duration of renal replacement therapy
and failure to normalize renal function after one year, is
also known to occur following HNV bite. Glomerulo-
sclerosis is the predominant histological finding [34,35].
Neurological effects
Direct neurological toxicity or effects on the neuromus-
cular junction have not been described in relation to
HNV envenoming. EEG abnormalities without clinical
neurological derangement have been observed in humans
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report of an ischemic stroke following HNV bite. In this
instance, the platelets were normal, and there was no evi-
dence of coagulopathy, although acute kidney injury that
had been present was resolved. It was suggested that the
pathophysiology was of a vaso-occlusive nature [32].
Effects on the heart
Transient ECG changes and symptoms suggestive of
cardiac involvement have been observed with HNV
envenoming. Electrolyte imbalance and hemodynamic
instability could contribute towards these. However, no
evidence of myocardial damage, characterized by ele-
vated cardiac troponin, has been demonstrated with
HNV envenoming [36].
Pulmonary effects
Pulmonary edema has been documented in humans fol-
lowing envenoming by Hypnale hypnale or Hypnale zara
[5,15]. However, there is no conclusive evidence to sug-
gest that lung injury occurs as a specific effect of HNV
envenoming. Studies in mice have shown that HNV
venom can induce pulmonary hemorrhage [18].
Gastrointestinal and liver effects
Nausea, vomiting, hematemesis (probably secondary to
coagulopathy) and abdominal pain have been reported [4].
However, hepatic dysfunction has not been described.
Treatment
Treatment is mainly symptomatic and supportive. Anal-
gesics, splinting of the bitten limb, wound care, and sur-
gical management including skin grafting constitute the
common approach employed against local envenoming.
In rare cases, amputation may be needed. Antibiotics are
often used routinely, despite lack of benefit in snakebite,
and tetanus toxoid is also administered [4,14,37]. Fea-
tures of systemic envenoming are treated with support-
ive care. Renal replacement therapy is the mainstay of
management of acute renal impairment, and may be-
come necessary if chronic kidney disease occurs conse-
quently [6,34,35]. Optimized administration of blood
components, correction of coagulopathy, and plasma ex-
change may be required when hematologic derange-
ments occur. No clear trial based evidence is available
showing benefit of these interventions. There are no spe-
cific protocols for managing envenoming following
HNV bite, and standard guidelines for snakebite man-
agement are followed [38].
Antivenom
No specific or polyvalent antivenom is available yet for
human use in HNV envenoming [39]. The currently
used polyvalent antivenom is ineffective in the treatmentof HNV envenomation, and is associated with a high in-
cidence of reactions [4,9,40]. In vivo animal studies
evaluating potential alternative antivenom preparations
for HNV show mixed results [21]. Trials in mice have
found hematopolyvalent antivenom to be efficacious
following experimental envenoming with H. hypnale
venom. This was shown to effectively prevent acute kid-
ney injury and death [41]. In vitro neutralization studies
showed that the hematopolyvalent antivenom effectively
neutralized the lethality of H. hypnale venom, as well as
the hemorrhagic, procoagulant, nephrotoxic, and nec-
rotic activities of the venom [39]. The monovalent Callo-
selasma rhodostoma antivenom also is also capable of
neutralizing the lethality and toxic activities of the
venom, but its potency was lower [41]. H. hypnale
venom elicited satisfactory titers of anti-Hypnale hypnale
IgG in rabbits after the third immunization. This anti-
Hypnale hypnale IgG, isolated using the caprylic acid
precipitation method, was effective in neutralizing venom
lethality (potency = 48 LD50 per mL IgG) as well as its
procoagulant, hemorrhagic and necrotic effects. This sug-
gests the potential to produce a specific antivenom [21].
Outcome
Survival and minor effects is the norm after HNV bites,
although fatalities are known to occur [2,4,11]. Chronic
kidney disease is a recognized complication, as described
above.
Conclusions
Formerly thought to result only in local envenoming,
HNV bite can result in serious sequelae including death.
Acute kidney injury and hematological manifestations
are the predominant serious effects. Clinically significant
neurotoxicity or cardiotoxicity does not occur. There are
two key areas for future research: firstly, identification of
clinical parameters and biochemical tests for early iden-
tification of systemic envenoming, i.e., early detection of
coagulopathy and nephrotoxicity; secondly, the develop-
ment of an efficacious specific antivenom for routine
use.
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